Category: Clinical Considerations
How a SARS-CoV-2 virus protein damages the heart?
(Tech Expert) Scientists at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how SARS-CoV-2 damages heart tissue. Last year, in research involving fruit flies and human cells, the most lethal SARS-CoV-2 proteins were discovered. They found a promising drug selinexor reduced the toxicity of one of these proteins but not the […]
Nov 8, 2022
Researchers create new model to detect COVID’s effects using chest X-rays
(Iowa Now) For patients dealing with lingering respiratory symptoms from the novel coronavirus, a chest X-ray can reveal only so much. The two-dimensional (2D) scans simply can’t distinguish compromised lung function. For that diagnosis, a more expensive, three-dimensional (3D) technique called a CT scan is necessary. Yet many medical clinics in the United States don’t have […]
Nov 1, 2022
Covid-19 Infection Linked With Poor Cardiovascular Outcomes And Death
(Forbes) A new UK study shows that being infected with Covid-19 is linked to an increased risk of poor cardiovascular health and death. The risk is greatest within the first 30 days of infection and for those whose infection required hospitalization, but the risk also remains heightened for those who did not experience a severe infection. When […]
Nov 1, 2022
‘A silent killer’ – COVID-19 shown to trigger inflammation in the brain
(University of Queensland) Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease. The discovery identified a potential future risk for neurodegenerative conditions in people who’ve had COVID-19, but also a possible treatment. The UQ team was led by Professor Trent Woodruff and Dr Eduardo Albornoz Balmaceda from UQ’s School […]
Nov 1, 2022
HIV Coinfection in Over 80% of Hospitalized Monkeypox Cases
(MedPageToday) In a cohort of patients hospitalized for monkeypox, four out of five had HIV and one in five died, CDC researchers said. Of the 57 adults hospitalized due to serious complications from monkeypox, 82.5% had HIV and 8.5% were receiving antiretroviral therapy, reported Maureen Miller, MD, of the CDC’s Monkeypox Emergency Response Team, and […]
Oct 28, 2022
Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis
(Healio Neurology) Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022. “Given the fact that this population has a different background, different culture and socioeconomic status, the outcomes aren’t necessarily going to be the same as those from high-income […]
Oct 27, 2022
People who caught mild Covid had increased risk of blood clots, British study finds
(NBC) Patients with mild Covid, defined as those not hospitalized, were 2.7 times more likely to develop blood clots, according to the study published in the British Medical Journal on Monday. Patients hospitalized with Covid were 27 times more likely to develop blood clots, 21 times more likely to suffer heart failure and 17 times […]
Oct 25, 2022
Anti-Inflammatory Agents May Have Role in COVID-19 Pneumonia
(MedPageToday) Infliximab and abatacept showed trends for improved outcomes in ACTIV-1 IM trial. Use of the anti-inflammatory agents infliximab (Remicade) and abatacept (Orencia) added to standard of care showed a hint of improvement in outcomes for patients hospitalized with COVID-19 pneumonia, according to results from the ACTIV-1 IM trial. Compared with a median time to […]
Oct 25, 2022
During the first year of the pandemic, men died from COVID at a much higher rate than women
(CDC) Death rates in the United States are higher in rural than urban areas, andthe difference has grown over the last 2 decades (1). Death rates for all ofthe 10 leading causes of death in 2019 were higher in rural than urban areas(1). In 2020, deaths due to COVID-19 became the third leading cause ofdeath […]
Oct 25, 2022
Pulmonary Rehab May Benefit Some Patients After Severe COVID
(MedPage Today) In patients with significant respiratory disability following hospitalizations for COVID, 8 weeks of daily, supervised pulmonary rehabilitation was associated with significant improvement in exercise tolerance and quality of life in a single-center, retrospective study from India. The analysis of outcomes among 57 hospitalized patients — including 10 who needed non-invasive ventilation and 32 […]
Oct 20, 2022